Showing 1921-1930 of 2038 results for "".
- Iveric Bio Appoints Pravin U. Dugel, MD, as Executive Vice President and Chief Strategy and Business Officerhttps://modernod.com/news/iveric-bio-appoints-pravin-u-dugel-md-as-executive-vice-president-and-chief-strategy-and-business-officer/2477448/Iveric bio announced the appointment of Pravin U. Dugel, MD, as Executive Vice President and Chief Strategy and Business Officer, effective April 1, 2020. In this role, Dr. Dugel will help shape Iveric bio’s business development strategy going forward. Dr. Dugel brings more than 25 years’ experie
- FDA Clamps Down On At-Home Coronavirus Testing, Citing Fake Products and Bad Actorshttps://modernod.com/news/fda-clamps-down-on-at-home-coronavirus-testing-citing-fake-products-and-bad-actors/2477444/After telling companies, laboratories and state health departments to move forward with emergency coronavirus testing without federal oversight or approval, the FDA is now working to rein in the ones it describes as going too far, according to a <
- Keeping Your Vision Safe During a Natural Disasterhttps://modernod.com/news/keeping-your-vision-safe-during-a-natural-disaster/2477424/Parkhurst Nuvision in San Antonio, Texas, posted the following advisory to its patients, which providing tips for managing vision needs in an emergency. When faced with the forces of nature – in particular flooding and contaminated waters – people who rely on contact lenses to see well fa
- OIS Plans to Hold Anterior Segment Meetinghttps://modernod.com/news/ois-plans-to-hold-anterior-segment-meeting/2477388/The organizers of the Ophthalmology Innovation Summit (OIS) released an email stating that they are still planning to move forward with the scheduled OIS Anterior Segment Summit on May 14. “Surprising as it may seem, the number of attendees and speakers committing to the OIS Anterior
- ImprimisRx Announces Supply Agreement with EyeCare Services Partnershttps://modernod.com/news/imprimisrx-announces-supply-agreement-with-eyecare-services-partners/2477379/ImprimisRx announced that it has agreed to a product supply agreement with EyeCare Services Partners (ESP). ImprimisRx currently provides a limited number of ophthalmic formulations to practices within the ESP group, but this agreement will expand the number of formulations availa
- ImprimisRx Announces Supply Agreement with iOR Partnershttps://modernod.com/news/imprimisrx-announces-supply-agreement-with-ior-partners/2477364/ImprimisRx announced that it has agreed to a product supply agreement with iOR Partners. Under the agreement, ImprimisRx will provide a variety of formulations needed for in-office surgeries, including the MKO Melt and various injectable and topical products.
- ImprimisRx Announces Supply Agreement with Vision Center Network of America (VCNA)https://modernod.com/news/imprimisrx-announces-supply-agreement-with-vision-center-network-of-america-vcna/2477342/ImprimisRx announced that it has agreed to a product supply agreement with Vision Center Network of America LLC (VCNA). The agreement will make ImprimisRx a VCNA preferred provider for a variety of surgical formulations, including a portfolio of topical and injectable products. Terms of t
- Retina Consultants of America Launches with Four Leading Partner Practiceshttps://modernod.com/news/retina-consultants-of-america-launches-with-four-leading-partner-practices/2477340/Retina Consultants of America (RCA), a physician management services organization recently formed by Webster Equity Partners, launched with four retina specialty practices. Practices include Retina Consultants of Houston, Retina Group of Florida, Long Island Vitreoretinal Consultants, and Retinal
- Graybug Vision Presents Preclinical Results for Glaucoma Drug Candidate GB-401https://modernod.com/news/graybug-vision-presents-preclinical-results-for-glaucoma-drug-candidate-gb-401/2477332/Graybug Vision presented preclinical study results for GB-401, a novel injectable depot formulation of a proprietary beta-adrenergic antagonist prodrug, as a potential sustained-delivery treatment of up to 6 months for primary open angle glaucoma (POAG), at the American Glaucoma Society annual me
- Two Chicago Ophthalmology Practices Receive Strategic Investment From MoonSail Capital And Plenary Partnershttps://modernod.com/news/two-chicago-ophthalmology-practices-receive-strategic-investment-from-moonsail-capital-and-plenary-partners/2477329/Chicago Eye Institute and Arbor Centers for EyeCare, two ophthalmology practices serving the Chicago market, announced that they have entered into a strategic partnership with private investment firms MoonSail Capital and Plenary Partners to form Ocular Partners.<